# Effects of Lactoferrin at Two Doses vs. Active Control on Markers of Immune Function

> **NCT06012669** · NA · COMPLETED · sponsor: **Midwest Center for Metabolic and Cardiovascular Research** · enrollment: 66 (actual)

## Conditions studied

- Immune Health

## Interventions

- **DIETARY_SUPPLEMENT:** High dose Human Lactoferrin
- **DIETARY_SUPPLEMENT:** Low dose Human Lactoferrin
- **DIETARY_SUPPLEMENT:** Active Control Bovine Lactoferrin

## Key facts

- **NCT ID:** NCT06012669
- **Lead sponsor:** Midwest Center for Metabolic and Cardiovascular Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-06
- **Primary completion:** 2023-12-27
- **Final completion:** 2023-12-27
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2025-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06012669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06012669, "Effects of Lactoferrin at Two Doses vs. Active Control on Markers of Immune Function". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06012669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*